| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -3.2% | +8.7% |
| Cost of Revenue | $1.0M | +13.1% | +7.6% |
| R&D Expense | $158K | -2.5% | -15.5% |
| SG&A Expense | $789K | -12.8% | -3.3% |
| Operating Income | $94K | -43.7% | +204.4% |
| Interest Expense | $37K | -2.6% | +5.7% |
| Net Income | $57K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.0M | -7.8% | +49.3% |
| Inventory | $1.6M | +2.6% | +15.0% |
| Current Assets | $3.7M | -2.8% | +7.0% |
| Total Assets | $5.3M | -4.8% | +2.0% |
| Current Liabilities | $4.7M | -5.8% | -1.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24K | — | — |
| Capital Expenditures | $40K | — | — |
| Investing Cash Flow | -$40K | — | — |
| Financing Cash Flow | -$200K | — | — |
| Free Cash Flow | -$64K | — | — |
| -55.8% |
| +145.6% |
| EPS (Basic) | $0.00 | -100.0% | +100.0% |
| EPS (Diluted) | $0.00 | -100.0% | +100.0% |
| $4.8M |
| -7.5% |
| -3.3% |
| Stockholders' Equity | -$3.8M | +3.1% | +6.6% |